Peter Gunnar Maurits Wolpert
Presidente presso Viscogel AB
Profilo
Peter Gunnar Maurits Wolpert was the founder of Accuro Immunology AB, established in 1995, where he served as Chairman from 1995 to 2009.
He was also the founder of Moberg Pharma AB, founded in 2006, where he held the position of Executive Chairman from 2019 to 2022.
Mr. Wolpert is currently the Chairman of Viscogel AB since 2012 and holds the position of Director at Med Universe AB.
In his former roles, he served as the Chief Executive Officer of Athera Biotechnologies AB, Director at Promore Pharma AB, Director at Wolco Invest AB, and Management Consultant at McKinsey & Co. Service AB.
Mr. Wolpert obtained a graduate degree from Stockholm School of Economics and a graduate degree from the Royal Institute of Technology.
Mr. Wolpert is also the founder of Ibility AB.
Posizioni attive di Peter Gunnar Maurits Wolpert
| Società | Posizione | Inizio |
|---|---|---|
| Viscogel AB | Presidente | 17/07/2013 |
Med Universe AB
 Med Universe AB Internet Software/ServicesTechnology Services Med Universe AB provides online social networking services for doctors. Its services include software as a service, insights over time and multi-channel usage. The company was founded by Anna Omstedt Lindgren and Anna Norin in 2009 and is headquartered in Stockholm, Sweden. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Peter Gunnar Maurits Wolpert
| Società | Posizione | Fine |
|---|---|---|
| MOBERG PHARMA AB | Amministratore Delegato | 15/05/2019 |
Ibility AB
 Ibility AB Personnel ServicesCommercial Services Ibility AB provides employment and recruitment services. The private company is based in Stockholm, Sweden. The Swedish company was founded by Peter Gunnar Maurits Wolpert. | Fondatore | - |
| Wolco Invest AB | Direttore/Membro del Consiglio | - |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Amministratore Delegato | - |
McKinsey & Co. Service AB
 McKinsey & Co. Service AB Miscellaneous Commercial ServicesCommercial Services Part of McKinsey & Co., Inc., McKinsey & Co. Service AB is a consulting company founded in 2005. The company is based in Stockholm, Sweden and provides consulting services. | Corporate Officer/Principal | - |
Formazione di Peter Gunnar Maurits Wolpert
| Royal Institute of Technology | Graduate Degree |
| Stockholm School of Economics | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MOBERG PHARMA AB | Health Technology |
| Aziende private | 8 |
|---|---|
Accuro Immunology AB
 Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
| Viscogel AB | |
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
McKinsey & Co. Service AB
McKinsey & Co. Service AB Miscellaneous Commercial ServicesCommercial Services Part of McKinsey & Co., Inc., McKinsey & Co. Service AB is a consulting company founded in 2005. The company is based in Stockholm, Sweden and provides consulting services. | Commercial Services |
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Health Technology |
| Wolco Invest AB | |
Ibility AB
Ibility AB Personnel ServicesCommercial Services Ibility AB provides employment and recruitment services. The private company is based in Stockholm, Sweden. The Swedish company was founded by Peter Gunnar Maurits Wolpert. | Commercial Services |
Med Universe AB
Med Universe AB Internet Software/ServicesTechnology Services Med Universe AB provides online social networking services for doctors. Its services include software as a service, insights over time and multi-channel usage. The company was founded by Anna Omstedt Lindgren and Anna Norin in 2009 and is headquartered in Stockholm, Sweden. | Technology Services |
- Borsa valori
- Insiders
- Peter Gunnar Maurits Wolpert
